950 Winter Street
25 articles about MC10
The study is sponsored by Neurocrine Biosciences and conducted in collaboration with the Huntington Study Group.
MC10 and University of Vermont Announce Partnership to Advance Understanding of Gait Abnormalities in Movement Disorders
MC10, Inc., the developer of BioStamp nPoint, an end-to-end system for physiological data collection and analytics, announced today a collaboration with the University of Vermont, a leading academic research institution.
MC10, Inc. Announces Collaboration with Northwestern University and Ann & Robert H. Lurie Children’s Hospital of Chicago: Innovating Precision Medicine Approaches to Improve Maternal-Infant Outcomes
This collaboration bridges MC10’s expertise in wearable health solutions, DevSci’s leading-edge research on how the prenatal environment shapes early brain and behavioral development, and Lurie Children’s expertise in research at the maternal-fetal interface.
MC10, Inc. Announces Collaboration with University of Rochester: Development Novel Digital Biomarkers for Central Nervous System Diseases
MC10, Inc., creators of the innovative wearable device BioStamp nPoint, and the University of Rochester announced today a collaboration on advancing methods of assessing Central Nervous System (CNS) diseases
MC10, Inc. and AbbVie (NYSE:ABBV) Announce Clinical Trials in Multiple Sclerosis Using the BioStamp nPoint® System
This innovative, patient-focused endeavor aims to explore the use of data from the nPoint® System in order to provide unique insights into MS clinical studies.
System is designed for use in clinical trials and research studies where collection of relevant data is needed.
MC10 Enters Strategic Collaboration With LabCorp, Including Equity Investment, to Advance Clinical Trial Innovation and Healthcare Diagnostics
As part of the collaboration, LabCorp has also made an equity investment into MC10.
MC10 And The Shirley Ryan AbilityLab Initiate Research Collaboration To Develop Novel Solutions For Neurodegenerative Disease And Motion Disability Rehabilitation
MC10 And UCB Group Complete Landmark Pharmaceutical / Technology Collaboration Evaluating Patient Monitoring In Parkinson’s